Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area
Rosales-Klintz, S., Bruchfeld, J., Haas, W., Heldal, E., Houben, R., van Kessel, F., Mandelbaum, M., Matteelli, A., Migliori, G.B., Oordt-Speets, A., Solovic, I., Vasakova, M., Verver, S., de Vlas, S.J., Vonk Noordegraaf-Schouten, M.J.M., de Vries, G., Zenner, D., van der Werf, M.J.
Accessibility and acceptability of infectious disease interventions among migrants in the eu/eea: A cerqual systematic review
Driedger, M., Mayhew, A., Welch, V., Agbata, E., Gruner, D., Greenaway, C., Noori, T., Sandu, M., Sangou, T., Mathew, C., Kaur, H., Pareek, M., Pottie, K.
'treatment is of primary importance, and social assistance is secondary': A qualitative study on the organisation of tuberculosis (TB) care and patients' experience of starting and staying on TB treatment in Riga, Latvia
Kielmann, K., Vidal, N., Riekstina, V., Krutikov, M., Werf, M.J.V., Biraua, E., Duric, P., Moore, D.A.J.
Preventing blood-borne viruses in prison settings: ECDC and EMCDDA Guidance
People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV often linked to a history of injecting drug use.
Social determinants and risk factors in tuberculosis surveillance in the EU/EEA
The objective of this report is to provide countries with advice on what social determinant and risk factor variables to collect and what definitions to use, and to propose information to be collected at the national and European level.
The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: A systematic review
Greenaway, C., Pareek, M., Chakra, C.-N.A., Walji, M., Makarenko, I., Alabdulkarim, B., Hogan, C., McConnell, T., Scarfo, B., Christensen, R., Tran, A., Rowbotham, N., van der Werf, M.J., Noori, T., Pottie, K., Matteelli, A., Zenner, D., Morton, R.L.
Cost-effectiveness analysis of programmatic screening strategies for latent tuberculosis infection in the EU/EEA
The elimination of tuberculosis (TB) in Europe will require the management of latent tuberculosis infection (LTBI) in key populations. Management of LTBI requires the identification and adequate treatment of infected people. It is currently unknown how screening and treatment of key populations should be best organised to have the highest impact with the available resources.
Disability weights for infectious diseases in four European countries: comparison between countries and across respondent characteristics.
De Noordhout, C.M., Devleesschauwer, B., Salomon, J.A., Turner, H., Cassini, A., Colzani, E., Speybroeck, N., Polinder, S., Kretzschmar, M.E., Havelaar, A.H., Haagsma, J.A.
Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA
This report presents the main findings of an ECDC project to assess the burden of infectious diseases among migrants in the EU/EEA based on available data for specific diseases: human immunodeficiency virus (HIV), tuberculosis (TB), hepatitis B, hepatitis C, gonorrhoea, syphilis, measles and rubella, malaria and Chagas disease.